Cargando…
Harnessing Liquid Biopsies to Guide Immune Checkpoint Inhibitor Therapy
SIMPLE SUMMARY: Cancer remains a major cause of morbidity and mortality for millions of people across the globe. While immunotherapy using immune-checkpoint inhibitors (ICIs) is revolutionizing the cancer field, the therapy many a times fails in numerous patients and is accompanied with life threate...
Autores principales: | Fatima, Shadma, Ma, Yafeng, Safrachi, Azadeh, Haider, Sana, Spring, Kevin J., Vafaee, Fatemeh, Scott, Kieran F., Roberts, Tara L., Becker, Therese M., de Souza, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997025/ https://www.ncbi.nlm.nih.gov/pubmed/35406441 http://dx.doi.org/10.3390/cancers14071669 |
Ejemplares similares
-
An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection
por: Safarchi, Azadeh, et al.
Publicado: (2021) -
Prognostic and Predictive Value of Liquid Biopsy-Derived Androgen Receptor Variant 7 (AR-V7) in Prostate Cancer: A Systematic Review and Meta-Analysis
por: Khan, Tanzila, et al.
Publicado: (2022) -
Pan-Cancer Analysis Reveals Functional Similarity of Three lncRNAs across Multiple Tumors
por: Khazaal, Abir, et al.
Publicado: (2023) -
Integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action
por: Azad, A.K.M., et al.
Publicado: (2021) -
Spectrochemical analysis of liquid biopsy harnessed to multivariate analysis towards breast cancer screening
por: Freitas, Daniel L. D., et al.
Publicado: (2020)